-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:06 AM
by
BOC Sciences, a leading chemical supplier, has partnered with Spaya, an AI-powered chemical synthesis platform, to enhance the portfolio of commercially available materials by listing an unprecedented 140,000+ chemical products.
Full story
-
Jan 2, 2024, 09:06 AM
by
Columbus, OH, December 18, 2023 - Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ: RARE) to perform late-stage Process Performance Qualification (PPQ) manufacturing of the company’s UX111 gene therapy for the potential treatment of Sanfilippo Syndrome (MPS IIIA).
Full story
-
Dec 28, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Genomenon launched Genomenon Curate-Pro variant classification service; Medidata launches the Medidata Research Alliance; Edinburgh Innovations has announced a novel 3D printed device that could replace the need for drug and chemical safety testing on animals; and more.
Full story
-
Dec 27, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Sanofi enters a multi-year research collaboration with French pharmatech company Aqemia; Apple Tree Partners will expand its portfolio company Deep Apple Therapeutics to rapidly discover novel small molecule therapeutics for high-value targets through virtual screening of AI-generated virtual libraries; Freya Biosciences intends to advance their multi-omics data science platform; and more.
Full story
-
Dec 21, 2023, 01:00 AM
by
User Not Found
Bio-IT World | In a turnaround of the usual metabolomics study approach, University of California San Diego scientists are homing in on the microbial-produced molecules that interact with cells and affect human health. A couple million such molecules are likely awaiting discovery in this fashion.
Full story
-
Dec 20, 2023, 09:15 AM
by
Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the Analysis of Neuromelanin-sensitive MRI
Full story
-
Dec 20, 2023, 09:15 AM
by
AppOmni, SaaS Security Posture Management (SSPM) leader and SaaS security pioneer, today unveiled a groundbreaking advancement with the introduction of AskOmni. This first AI-powered SSPM assistant developed by the AppOmni OmniScience team propels SSPM into new dimensions, simplifying security operations and issue remediation, and helping organizations secure mission-critical SaaS environments.
Full story
-
Dec 20, 2023, 09:15 AM
by
Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development, and diagnostics, today announced that it has entered into a collaboration agreement with MSD, the trade name of Merck & Co Inc., Rahway NJ USA to develop and commercialize AI-powered digital pathology diagnostics for the EU market.
Full story
-
Dec 20, 2023, 09:15 AM
by
Full story
-
Dec 20, 2023, 09:15 AM
by
Abzena, a leading CDMO for biologics, collaborates with the FDA on a publication endorsing the MHC Associated Peptide Proteomics (MAPPs) assay for assessing immunogenicity in drug development. The article underscores MAPPs' precision in identifying potential immunogenicity risks in early preclinical stages, reducing the likelihood of anti-drug antibodies (ADAs) and optimizing biologics. Abzena integrates MAPPs into its immunogenicity services, aiming to de-risk drug development. The Chief Scientific Officer, Dr. Campbell Bunce, emphasizes the assay's value in informing drug regions that may induce ADAs. The collaboration aims to expedite safer, more effective therapies for patients.
Full story
-
Dec 20, 2023, 09:15 AM
by
Full story
-
Dec 20, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Driven by advancements in technology and data accessibility, computational methods and artificial intelligence (AI) have seen remarkable growth this past decade. This surge has ushered in a new era of problem-solving across a plethora of industries and domains.
Full story
-
Dec 19, 2023, 09:29 AM
by
PubHive Navigator Enterprise Portal consolidates all workspaces, virtual libraries, folders, and internal content into one intuitive research platform, streamlining tailored research workflow and collaboration.
Full story
-
Dec 19, 2023, 09:29 AM
by
Hi
Hope you are well and are having a great week so far!
I just wanted to pass on the latest news from Recipharm, who has chosen Veeva Systems to streamline global quality operations. The move aims to enhance oversight, resource efficiency, validation speed, and inspection readiness.
The full release is below.
Thank you
Charlotte
Full story
-
Dec 19, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Driven by advancements in technology and data accessibility, computational methods and artificial intelligence (AI) have seen remarkable growth this past decade. This surge has ushered in a new era of problem-solving across a plethora of industries and domains.
Full story
-
Dec 18, 2023, 08:49 AM
by
Full story
-
Dec 18, 2023, 08:49 AM
by
Leading computational biology company PrecisionLife®, which is driving precision medicine in complex chronic diseases, the ME/CFS charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh have been awarded a £622,000 grant by Innovate UK's Advancing Precision Medicine programme to improve diagnosis and treatment for the millions of people affected by ME/CFS and long Covid.
Full story
-
Dec 18, 2023, 08:49 AM
by
Full story